TELA Bio (TELA) Total Current Liabilities (2018 - 2026)

TELA Bio's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $17.8 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 7.84% year-over-year to $17.8 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 7.84% increase from a year earlier, with the FY2025 full-year figure at $18.0 million, up 15.24% from the prior year.
• Total Current Liabilities retreated to $17.8 million in Q1 2026 per TELA's latest filing, from $18.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $19.1 million in Q2 2025 and bottomed at $11.9 million in Q2 2022.
• The 5-year median for Total Current Liabilities is $15.3 million (2023), against an average of $15.4 million.
• Across the five-year window, Total Current Liabilities jumped 117.91% in 2022 and slipped 8.07% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $12.4 million in 2022, then soared by 36.8% to $17.0 million in 2023, then declined by 8.07% to $15.6 million in 2024, then rose by 15.24% to $18.0 million in 2025, then retreated by 0.79% to $17.8 million in 2026.
• Per Business Quant, the three latest TELA Total Current Liabilities figures stand at $17.8 million (Q1 2026), $18.0 million (Q4 2025), and $17.0 million (Q3 2025).